BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23496263)

  • 1. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
    Doukky R; Gage H; Nagarajan V; Demopoulos A; Cena M; Garcia-Sayan E; Karam GJ; Kazlauskaite R
    Echocardiography; 2013 Sep; 30(8):889-95. PubMed ID: 23496263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study.
    Pant R; Patel M; Garcia-Sayan E; Wassouf M; D'Silva O; Kehoe RF; Doukky R
    Cardiovasc Ultrasound; 2016 Jan; 14():4. PubMed ID: 26772738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Clinical Determinants of Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation Before Pulmonary Vein Isolation.
    Nishikii-Tachibana M; Murakoshi N; Seo Y; Xu D; Yamamoto M; Ishizu T; Atsumi A; Machino-Ohtsuka T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    Am J Cardiol; 2015 Nov; 116(9):1368-73. PubMed ID: 26358509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
    Doukky R; Garcia-Sayan E; Gage H; Nagarajan V; Demopoulos A; Cena M; Nazir NT; Karam GJ; Trohman RG; Kazlauskaite R
    Cardiovasc Ultrasound; 2014 Feb; 12():10. PubMed ID: 24568305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function.
    Harada M; Tabako S; Fujii Y; Takarada Y; Hayashi K; Ohara H; Hara F; Ikeda T
    J Echocardiogr; 2018 Jun; 16(2):72-80. PubMed ID: 29256043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting left atrial thrombi in atrial fibrillation.
    Wysokinski WE; Ammash N; Sobande F; Kalsi H; Hodge D; McBane RD
    Am Heart J; 2010 Apr; 159(4):665-71. PubMed ID: 20362727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-Time Pathophysiologic Correlates of Left Atrial Appendage Thrombus in Patients Who Underwent Transesophageal-Guided Electrical Cardioversion for Atrial Fibrillation.
    Melduni RM; Gersh BJ; Wysokinski WE; Ammash NM; Friedman PA; Hodge DO; Chandrasekaran K; Oh JK; Lee HC
    Am J Cardiol; 2018 Jun; 121(12):1540-1547. PubMed ID: 29609898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Atrial Appendage Thrombus in Transcatheter Aortic Valve Replacement: Incidence, Clinical Impact, and the Role of Cardiac Computed Tomography.
    Palmer S; Child N; de Belder MA; Muir DF; Williams P
    JACC Cardiovasc Interv; 2017 Jan; 10(2):176-184. PubMed ID: 28104212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification of patients with left atrial appendage thrombus prior to catheter ablation of atrial fibrillation: An approach towards an individualized use of transesophageal echocardiography.
    Gunawardene MA; Dickow J; Schaeffer BN; Akbulak RÖ; Lemoine MD; Nührich JM; Jularic M; Sinning C; Eickholt C; Meyer C; Moser JM; Hoffmann BA; Willems S
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1127-1136. PubMed ID: 28635023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Patients at High Risk of Left Atrial Appendage Thrombus Before Cardioversion: The CLOTS-AF Score.
    Segan L; Nanayakkara S; Spear E; Shirwaiker A; Chieng D; Prabhu S; Sugumar H; Ling LH; Kaye DM; Kalman JM; Voskoboinik A; Kistler PM
    J Am Heart Assoc; 2023 Jun; 12(12):e029259. PubMed ID: 37301743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new risk model of assessing left atrial appendage thrombus in patients with atrial fibrillation - Using multiple clinical and transesophageal echocardiography parameters.
    Chen L; Zinda A; Rossi N; Han XJ; Sprankle S; Bullock-Palmer R; Zingrone D; Moshiyakov M; Szawlewicz J; Mogtader A; Hsi DH
    Int J Cardiol; 2020 Sep; 314():60-63. PubMed ID: 32305560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation.
    Okada Y; Shibazaki K; Kimura K; Matsumoto N; Iguchi Y; Aoki J; Kobayashi K; Sakai K
    J Neurol Sci; 2011 Feb; 301(1-2):86-9. PubMed ID: 21094497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation.
    Suo Y; Zhang Y; Wang Y; Yuan M; Kariyawasam S; Tse G; Liu T; Fu H; Li G
    Cardiol J; 2018; 25(5):611-620. PubMed ID: 28980280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation.
    Ammash N; Konik EA; McBane RD; Chen D; Tange JI; Grill DE; Herges RM; McLeod TG; Friedman PA; Wysokinski WE
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2760-6. PubMed ID: 21852562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of left atrial appendage thrombus and spontaneous echo contrast on transesophageal echocardiography in patients scheduled for pulmonary vein isolation.
    Mannewald C; Roijer A; Platonov PG; Holmqvist F
    Ann Noninvasive Electrocardiol; 2024 May; 29(3):e13119. PubMed ID: 38682420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a nomogram superior to CHADS
    Sun S; Ma C; Li Y; Lin J; Qian X
    J Thorac Dis; 2024 Mar; 16(3):2102-2114. PubMed ID: 38617765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of left atrial appendage thrombus despite NOAC use in nonvalvular atrial fibrillation and flutter.
    Shah M; Mobaligh N; Niku A; Shiota T; Siegel RJ; Rader F
    Int J Cardiol; 2020 Oct; 317():86-90. PubMed ID: 32344001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High plasma human atrial natriuretic peptide and reduced transthoracic left atrial appendage wall-motion velocity are noninvasive surrogate markers for assessing thrombogenesis in patients with paroxysmal atrial fibrillation.
    Yoshida N; Okamoto M; Hirao H; Suenari K; Nanba K; Uchida M; Yamazato R; Watari Y; Fukuda Y; Ueda H
    Echocardiography; 2014 Sep; 31(8):965-71. PubMed ID: 24373054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the N-terminal plasma brain natriuretic peptide levels or elevated left ventricular filling pressure and thromboembolic risk in patients with non-valvular atrial fibrillation.
    Yu GI; Cho KI; Kim HS; Heo JH; Cha TJ
    J Cardiol; 2016 Aug; 68(2):110-6. PubMed ID: 26775889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of a novel transthoracic echocardiographic tool in predicting left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation.
    Doukky R; Khandelwal A; Garcia-Sayan E; Gage H
    Eur Heart J Cardiovasc Imaging; 2013 Sep; 14(9):876-81. PubMed ID: 23291395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.